AI in drug manufacturing: Stakeholders call for harmonization, further guidance
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaPharmaceuticalsProduct Lifecycle